NCT06669936View on ClinicalTrials.gov

Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

October 1, 2024

Study Completion Date

October 28, 2024

Conditions
Recurrent C. Difficile Infection
Interventions
DRUG

Fecal microbiota transplantation ± bezlotoxumab

Co-administration of bezlotoxumab and FMT in patients with recurrent C. difficile infections who failed FMT alone.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

Alexander Khoruts

OTHER

NCT06669936 - Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection | Biotech Hunter | Biotech Hunter